Lombard Odier Asset Management (Europe)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,930
| Closed | -$9.66M | – | 171 |
|
|
2025
Q1 | $9.66M | Buy |
19,930
+957
| +5% | +$464K | 0.78% | 50 |
|
|
2024
Q4 | $7.64M | Sell |
18,973
-1,261
| -6% | -$508K | 0.49% | 74 |
|
|
2024
Q3 | $9.41M | Sell |
20,234
-9,703
| -32% | -$4.51M | 0.4% | 83 |
|
|
2024
Q2 | $14M | Buy |
+29,937
| New | +$14M | 0.66% | 40 |
|
|
2020
Q4 | – | Sell |
-2,588
| Closed | -$704K | – | 389 |
|
|
2020
Q3 | $704K | Buy |
+2,588
| New | +$704K | 0.04% | 140 |
|
|
2020
Q2 | – | Sell |
-2,588
| Closed | -$616K | – | 280 |
|
|
2020
Q1 | $616K | Hold |
2,588
| – | – | 0.05% | 140 |
|
|
2019
Q4 | $567K | Hold |
2,588
| – | – | 0.04% | 174 |
|
|
2019
Q3 | $438K | Hold |
2,588
| – | – | 0.04% | 208 |
|
|
2019
Q2 | $475K | Hold |
2,588
| – | – | 0.04% | 190 |
|
|
2019
Q1 | $476K | Hold |
2,588
| – | – | 0.05% | 171 |
|
|
2018
Q4 | $429K | Hold |
2,588
| – | – | 0.04% | 181 |
|
|
2018
Q3 | $499K | Hold |
2,588
| – | – | 0.03% | 185 |
|
|
2018
Q2 | $440K | Hold |
2,588
| – | – | 0.03% | 189 |
|
|
2018
Q1 | $422K | Sell |
2,588
-226
| -8% | -$36.9K | 0.03% | 199 |
|
|
2017
Q4 | $422K | Sell |
2,814
-368
| -12% | -$55.2K | 0.03% | 215 |
|
|
2017
Q3 | $484K | Hold |
3,182
| – | – | 0.03% | 217 |
|
|
2017
Q2 | $410K | Hold |
3,182
| – | – | 0.02% | 238 |
|
|
2017
Q1 | $348K | Sell |
3,182
-284
| -8% | -$31.1K | 0.02% | 258 |
|
|
2016
Q4 | $255K | Buy |
3,466
+400
| +13% | +$29.4K | 0.09% | 281 |
|
|
2016
Q3 | $267K | Hold |
3,066
| – | – | 0.09% | 295 |
|
|
2016
Q2 | $264K | Buy |
+3,066
| New | +$264K | 0.01% | 316 |
|